Efficacy and safety of a ceramide containing moisturizer followed by fixed-dose clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel in the morning in combination with a ceramide containing moisturizer followed by tretinoin 0.05% gel in the evening for the treatment of facial acne vulgaris

J Drugs Dermatol. 2012 Jun;11(6):748-52.

Abstract

Combination therapy addressing multiple pathogenic factors should be used to achieve optimal outcomes in treating acne. The following study demonstrated both safety and efficacy of fixed-dose clindamycin phosphate 1.2%/benzoyl peroxide 2.5% in the morning with micronized tretinoin 0.05% gel in the evening. Both products were applied to the skin following the use of a ceramide containing moisturizing lotion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acne Vulgaris / drug therapy*
  • Acne Vulgaris / pathology
  • Administration, Cutaneous
  • Adolescent
  • Adult
  • Benzoyl Peroxide / administration & dosage*
  • Benzoyl Peroxide / adverse effects
  • Ceramides / administration & dosage*
  • Ceramides / adverse effects
  • Clindamycin / administration & dosage
  • Clindamycin / adverse effects
  • Clindamycin / analogs & derivatives*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Gels
  • Humans
  • Male
  • Treatment Outcome
  • Tretinoin / administration & dosage*
  • Tretinoin / adverse effects
  • Young Adult

Substances

  • Ceramides
  • Gels
  • Clindamycin
  • Tretinoin
  • clindamycin phosphate
  • Benzoyl Peroxide